Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHeiq Regulatory News (HEIQ)

  • There is currently no data for HEIQ

Director/PDMR Shareholding

18 Nov 2024 07:00

RNS Number : 5192M
HeiQ PLC
18 November 2024
Β 

18 November 2024

Β 

HeiQ Plc

("HeiQ" or "the Company")

Director / PDMR Dealing

HeiQ Plc (LSE: HEIQ), a leading company in materials innovation and hygiene technologies, has been notified that on 15 December 2024, Xaver Hangartner, Chief Finance Officer, and Karen Brade, Non-Executive Director, purchased shares in the company, as follows:

Name

Number of Shares

Price

Xaver Hangartner

139,694

100,000

Β£0.040

Β£0.041

Karen Brade

40,263

Β£0,0471

Β 

Following the purchases, Mr. Hangartner holds an interest in 806,808 Ordinary Shares and Ms. Brade holds an interest in 80,526 Ordinary Shares, representing approximately 0.48% and 0.05% per cent. of the Company's issued ordinary share capital respectively.

This announcement, including the notification below, is made in accordance with the requirements of the UK Market Abuse Regulation.

Β 

Β 

1

Β 

Details of the person discharging managerial responsibilities / person closely associated

Β 

a)

Β 

Name

Β 

Β 

(i) Mr. Xaver Hangartner

(ii) Ms. Karen Brade

2

Β 

Reason for the notification

Β 

a)

Β 

Position/status

Β 

Β 

(i) Chief Finance Officer

(ii) Non-Executive Director

b)

Β 

Initial notification /Amendment

Β 

Β 

Initial Notification

3

Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Β 

a)

Β 

Name

Β 

Β 

HeiQ plc

b)

Β 

LEI

Β 

Β 

213800IGT65IMJDO4S03

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Β 

Β 

a)

Β 

Description of the financial instrument, type of instrument

Β 

Identification code

Β 

Β 

Ordinary Shares of GBP 0.05 each

Β 

Β 

GB00BN2CJ299

Β 

b)

Β 

Nature of the transaction

Β 

Β 

Purchase of Ordinary Shares

c)

Β 

Price(s) and volume(s)

Β 

Β 

Β 

Name

Price(s)

Β 

Volume(s)

(i) Mr Xaver Hangartner

0.040 and 0.041

139,694 and 100,000

(ii) Ms Karen Brade

0.0471

Β 

40,263

Β 

Β 

d)

Β 

Aggregated information

Β 

Β 

- Aggregated volume

Β 

Β 

- Price

Β 

Β 

N/A

Β 

Β 

Β 

Β 

Β 

Β 

Β 

e)

Β 

Date of the transaction

Β 

Β 

Β 15 November 2024

f)

Β 

Place of the transaction

Β 

Β 

London Stock Exchange, Main Market

Β 

Β For further information, please contact:

HeiQ Plc

Carlo Centonze (CEO)

+41 56 250 68 50

Cenkos Securities plc (Joint Broker)

Stephen Keys / Callum Davidson

+44 (0) 207 397 8900

SEC Newgate (Media Enquiries)

Elisabeth Cowell / Tom Carnegie / Molly Gretton

+44 (0) 20 3757 6882

HeiQ@secnewgate.co.uk

Β 

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
DSHFIFLTLLLDLIS
Date   Source Headline
18th Nov 20247:00 amRNSDirector/PDMR Shareholding
14th Nov 20247:00 amRNSUpdate on Delisting and Potential Capital Raise
31st Oct 20247:01 amRNSNotice of AGM
31st Oct 20247:00 amRNSResults for 18-month period ended 30 June 2024
24th Oct 202411:26 amRNSHolding(s) in Company
22nd Oct 20247:00 amRNSRestructuring and Delisting
18th Sep 202411:45 amRNSHolding(s) in Company
16th Sep 20249:03 amRNSDirector/PDMR Shareholding
12th Sep 20247:00 amRNSTrading Update
16th Jul 20247:00 amRNSHeiq AeoniQ Capital Raising
30th May 20247:00 amRNSChange of Auditor
22nd Apr 20247:00 amRNSHeiQ Synbio Secures Ecolab Contract Win
16th Apr 20242:17 pmRNSHolding(s) in Company
28th Mar 20247:00 amRNSUnaudited Interim Results
18th Mar 202412:41 pmRNSHolding(s) in Company
15th Mar 20247:00 amRNSHolding(s) in Company
14th Mar 20241:23 pmRNSCompletion of Fundraising, PDMR & Audit Update
13th Mar 20242:26 pmRNSResult of General Meeting
12th Mar 20247:00 amRNSBoard Changes
23rd Feb 20247:00 amRNSResult of Retail Offer
16th Feb 20247:00 amRNSResult of Placing
15th Feb 20245:49 pmRNSRetail Offer
15th Feb 20245:46 pmRNSAcquisition, Fundraising, Trading Update & GM
6th Dec 20232:46 pmRNSAgreed Changes to Concert Party
4th Dec 20237:00 amRNSDirector/PDMR Dealing
1st Dec 20233:04 pmRNSResult of General Meeting
30th Nov 20237:06 amRNSStatement Confirming Settlement
27th Nov 20237:00 amRNSBoard Appointment
8th Nov 20237:00 amRNSNotice of General Meeting
3rd Nov 20239:14 amRNSHolding(s) in Company
3rd Nov 20237:05 amRNSHolding(s) in Company
31st Oct 20237:43 amRNSFiling of Annual Report & Restoration of Trading
31st Oct 20237:30 amRNSRestoration - HEIQ PLC
30th Oct 20237:01 amRNSInterim Results
30th Oct 20237:00 amRNSResults for year ended 31 December 2022
23rd Oct 20237:00 amRNSNotice of Results and Audit Update
29th Sep 20237:00 amRNSAccounts Update
6th Jul 20237:00 amRNSMAS Holdings invests in HeiQ AeoniQ
29th Jun 20232:16 pmRNSResult of AGM
29th Jun 20237:00 amRNSAGM Statement
6th Jun 20237:00 amRNSNotice of AGM
2nd May 20237:44 amRNSTemporary Suspension of Trading in Ordinary Shares
27th Apr 20233:55 pmRNSTemporary Suspension
13th Jan 20232:09 pmRNSUpdate re. admission of Consideration Shares
12th Jan 20237:00 amRNSCompletion of Acquisition
10th Jan 20237:00 amRNSDirector / PDMR Dealing
6th Jan 20237:00 amRNSDirector / PDMR Dealing
5th Jan 20237:03 amRNSDirector/PDMR Shareholding
4th Jan 20237:00 amRNSTrading Update and Acquisition
14th Dec 20227:00 amRNSIncreased interest in HeiQ Chrisal to 71%

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.